Mutant fragments of ospa and methods and uses relating thereto
US-2016333056-A1 · Nov 17, 2016 · US
Reagent for assaying anti-treponema pallidum antibody
US8969520B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8969520-B2 |
| Application number | US-201113638622-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 31, 2011 |
| Priority date | Mar 31, 2010 |
| Publication date | Mar 3, 2015 |
| Grant date | Mar 3, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
To provide a reagent for assaying anti- Treponema pallidum antibody which reagent contains a polypeptide antigen and which reagent provides high assay sensitivity and high specificity, and to provide an assay method employing the assay reagent. The reagent for assaying anti- Treponema pallidum antibody, for use in an assay of anti- Treponema pallidum antibody on the basis of antigen-antibody reaction is characterized in that the reagent contains, as an antigen, a recombinant polypeptide containing at least domain C and domain D of Treponema pallidum 47 kDa antigen but containing no domain A1 of the 47 kDa antigen.
First claim
Opening claim text (preview).
The invention claimed is: 1. A reagent for assaying anti- Treponema pallidum antibody, based on an antigen-antibody reaction, wherein the reagent comprises, as an antigen, a recombinant polypeptide comprising at least domain C and domain D of Treponema pallidum 47 kDa antigen encoded by the nucleic acid comprising SEQ ID NO:34 and lacking domain A1 of the 47 kDa antigen, wherein the domain A1 is formed of amino acids 1-34 of domain A of the Treponema pallidum 47 kDa antigen, w…
Assignees
Inventors
Classifications
Physics · mapped topic
Physics · mapped topic
- C07K14/20Primary
Chemistry & Metallurgy · mapped topic
Physics · mapped topic
Physics · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8969520B2 cover?
- To provide a reagent for assaying anti- Treponema pallidum antibody which reagent contains a polypeptide antigen and which reagent provides high assay sensitivity and high specificity, and to provide an assay method employing the assay reagent. The reagent for assaying anti- Treponema pallidum antibody, for use in an assay of anti- Treponema pallidum antibody on the basis of antigen-an…
- Who is the assignee on this patent?
- Hara Yasuyuki, Ota Tetsuya, Kawamoto Michiko, and 6 more
- What technology area does this patent fall under?
- Primary CPC classification C07K14/20. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).